The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

Alex Oxlade-Chamberlain insists he is ready to make a splash in the Premier League - just months after Turkish club Besiktas terminated his contract. He is training with Arsenal's under-21s and has ...